Gel-del Technologies, Inc.

St. Paul, MN 55114

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $6.18MM
First Award Date 01/03/03
Most Recent Award Date 08/01/11

Key Personnel

Last Name Name Awards Contact
Masters David B Masters 8

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HD-09-017
Budget: 08/01/11 - 07/31/13

DESCRIPTION (provided by applicant): Pre-mature and critically ill infants often require frequent medication and nutrient administration, necessitating use of peripheral intravenous catheters for prolonged periods. Due to the small diameter of these newborns'veins, these catheters demonstrate a propensity for clotting, limiting their use and pot...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 06/01/11 - 05/31/13

DESCRIPTION (provided by applicant): Peripheral artery disease and trauma are leading causes of morbidity and amputation in the United States. Recent advances in biomaterials provide for potential development of small diameter vascular grafts as a life-saving treatment. Development of a life-long graft (<6 mm id) requires a construct that will n...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HD-09-017
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): Pre-mature and critically ill infants often require frequent medication and nutrient administration, necessitating use of peripheral intravenous catheters for prolonged periods. Due to the small diameter of these newborns'veins, these catheters demonstrate a propensity for clotting, limiting their use and pot...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 06/01/10 - 05/31/11

DESCRIPTION (provided by applicant): Peripheral artery disease and trauma are leading causes of morbidity and amputation in the United States. Recent advances in biomaterials provide for potential development of small diameter vascular grafts as a life-saving treatment. Development of a life-long graft (<6 mm id) requires a construct that will n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 06/01/09 - 05/31/10

DESCRIPTION (provided by applicant): Peripheral artery disease and trauma are leading causes of morbidity and amputation in the United States. Recent advances in biomaterials provide for potential development of small diameter vascular grafts as a life-saving treatment. Development of a life-long graft (<6 mm id) requires a construct that will n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/07 - 03/31/09

DESCRIPTION (provided by applicant): Atherosclerotic vascular disease, in the form of coronary artery and peripheral vascular disease, is the leading cause of mortality in the United States. Despite vast improvements in the field of biomaterials, a useful biocompatible material is still not available for the production of small vascular grafts l...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/06 - 03/31/07

DESCRIPTION (provided by applicant): Atherosclerotic vascular disease, in the form of coronary artery and peripheral vascular disease, is the leading cause of mortality in the United States. Despite vast improvements in the field of biomaterials, a useful biocompatible material is still not available for the production of small vascular grafts l...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/03/03 - 12/31/03

DESCRIPTION (provided by applicant): The development of an alternative to the currently available synthetic vascular prosthesis is of great value. Atherosclerosis vascular disease, in the form of coronary artery and peripheral vascular disease, is the leading cause of mortality in the United States. Despite vast improvements in the field of biom...